Ophthalmic phototherapy device and associated treatment method
First Claim
Patent Images
1. An ophthalmic phototherapy device for treating inflammatory eye disease inside an eye of a patient, said ophthalmic phototherapy device comprising:
- a first light emitting mechanism comprising one or more arrays of LED(s), low power laser source(s), or any combination thereof, for emitting light of at least a first wavelength between approximately 490 nm and 810 nm;
a second light emitting mechanism comprising one or more arrays of LED(s), low power laser source(s), or any combination thereof, for emitting light of at least a second wavelength, wherein said first and second wavelengths are different; and
a controller comprising at least one microprocessor, said controller configured to control said first and second light emitting mechanisms so as to selectively direct light of said first and second wavelengths from the device into the eye of the patient being treated by the ophthalmic phototherapy device for first and second preselected periods of time, respectively.
1 Assignment
0 Petitions
Accused Products
Abstract
An ophthalmic phototherapy device and associated phototherapy treatment method for promoting healing of damaged or diseased eye tissue. The ophthalmic phototherapy device includes a light emitting mechanism for transmitting light of at least one preselected wavelength to the eye tissue. The ophthalmic phototherapy method includes directing light of at least one wavelength for a selected period of time to a portion of damaged or diseased eye tissue, whereby the light transmitted to the damaged or diseased eye tissue stimulates cellular activity in the eye tissue to promote healing.
-
Citations
32 Claims
-
1. An ophthalmic phototherapy device for treating inflammatory eye disease inside an eye of a patient, said ophthalmic phototherapy device comprising:
-
a first light emitting mechanism comprising one or more arrays of LED(s), low power laser source(s), or any combination thereof, for emitting light of at least a first wavelength between approximately 490 nm and 810 nm; a second light emitting mechanism comprising one or more arrays of LED(s), low power laser source(s), or any combination thereof, for emitting light of at least a second wavelength, wherein said first and second wavelengths are different; and a controller comprising at least one microprocessor, said controller configured to control said first and second light emitting mechanisms so as to selectively direct light of said first and second wavelengths from the device into the eye of the patient being treated by the ophthalmic phototherapy device for first and second preselected periods of time, respectively. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18)
-
-
19. An ophthalmic phototherapy device for treating inflammatory eye disease inside an eye of a patient, said ophthalmic phototherapy device comprising:
-
a first light emitting mechanism comprising one or more arrays of LED(s), low power laser source(s), or any combination thereof, for emitting light of at least a first wavelength; a second light emitting mechanism comprising one or more arrays of LED(s), low power laser source(s), or any combination thereof, for emitting light of at least a second wavelength; a third light emitting mechanism comprising one or more arrays of LED(s), low power laser source(s), or any combination thereof, for emitting light of at least a third wavelength, wherein said first, second and third wavelengths are different from each other and are each selected from a near infra-red light wavelength, a yellow light wavelength and a red light wavelength; and a controller comprising at least one microprocessor, said controller configured to control said first, second and third light emitting mechanisms so as to selectively direct light of said first, second and third wavelengths from the device into the eye of the patient being treated by the ophthalmic phototherapy device for one or more preselected periods of time, respectively. - View Dependent Claims (20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32)
-
Specification